160 related articles for article (PubMed ID: 23341442)
1. Elevated nuclear factor erythroid-2 levels promote epo-independent erythroid maturation and recapitulate the hematopoietic stem cell and common myeloid progenitor expansion observed in polycythemia vera patients.
Bogeska R; Pahl HL
Stem Cells Transl Med; 2013 Feb; 2(2):112-7. PubMed ID: 23341442
[TBL] [Abstract][Full Text] [Related]
2. NF-E2 overexpression delays erythroid maturation and increases erythrocyte production.
Mutschler M; Magin AS; Buerge M; Roelz R; Schanne DH; Will B; Pilz IH; Migliaccio AR; Pahl HL
Br J Haematol; 2009 Jul; 146(2):203-17. PubMed ID: 19466964
[TBL] [Abstract][Full Text] [Related]
3. Increased erythropoiesis in polycythemia vera is associated with increased erythroid progenitor proliferation and increased phosphorylation of Akt/PKB.
Dai C; Chung IJ; Krantz SB
Exp Hematol; 2005 Feb; 33(2):152-8. PubMed ID: 15676208
[TBL] [Abstract][Full Text] [Related]
4. Depletion of L3MBTL1 promotes the erythroid differentiation of human hematopoietic progenitor cells: possible role in 20q- polycythemia vera.
Perna F; Gurvich N; Hoya-Arias R; Abdel-Wahab O; Levine RL; Asai T; Voza F; Menendez S; Wang L; Liu F; Zhao X; Nimer SD
Blood; 2010 Oct; 116(15):2812-21. PubMed ID: 20585043
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling in polycythaemia vera: overexpression of transcription factor NF-E2.
Goerttler PS; Kreutz C; Donauer J; Faller D; Maiwald T; März E; Rumberger B; Sparna T; Schmitt-Gräff A; Wilpert J; Timmer J; Walz G; Pahl HL
Br J Haematol; 2005 Apr; 129(1):138-50. PubMed ID: 15801966
[TBL] [Abstract][Full Text] [Related]
6. Polycythemia vera erythroid precursors exhibit increased proliferation and apoptosis resistance associated with abnormal RAS and PI3K pathway activation.
Laubach JP; Fu P; Jiang X; Salter KH; Potti A; Arcasoy MO
Exp Hematol; 2009 Dec; 37(12):1411-22. PubMed ID: 19815050
[TBL] [Abstract][Full Text] [Related]
7. In vitro erythropoiesis in polycythemia vera and other myeloproliferative disorders.
Weinberg RS
Semin Hematol; 1997 Jan; 34(1):64-9. PubMed ID: 9025164
[TBL] [Abstract][Full Text] [Related]
8. Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor.
Dai CH; Krantz SB; Dessypris EN; Means RT; Horn ST; Gilbert HS
Blood; 1992 Aug; 80(4):891-9. PubMed ID: 1498332
[TBL] [Abstract][Full Text] [Related]
9. End-stage renal disease following polycythemia vera: in vitro and in vivo response of erythroid progenitors to erythropoietin and effects of sera on normal erythropoiesis.
Shih LY; Huang JY
Nephron; 1998; 79(2):142-7. PubMed ID: 9647492
[TBL] [Abstract][Full Text] [Related]
10. Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera.
Ugo V; Marzac C; Teyssandier I; Larbret F; Lécluse Y; Debili N; Vainchenker W; Casadevall N
Exp Hematol; 2004 Feb; 32(2):179-87. PubMed ID: 15102479
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of hydroxyurea transporters in normal and polycythemia vera hematopoietic stem and progenitor cell subpopulations.
Tan G; Meier-Abt F
Exp Hematol; 2021 May; 97():47-56.e5. PubMed ID: 33677043
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human mast cell growth factor supports erythroid colony formation in polycythemia vera in the presence and absence of erythropoietin and serum.
Muller EW; de Wolf JT; Hendriks DW; Esselink MT; Halie MR; Vellenga E
Exp Hematol; 1993 Sep; 21(10):1353-7. PubMed ID: 7689483
[TBL] [Abstract][Full Text] [Related]
13. RUNX1 and NF-E2 upregulation is not specific for MPNs, but is seen in polycythemic disorders with augmented HIF signaling.
Kapralova K; Lanikova L; Lorenzo F; Song J; Horvathova M; Divoky V; Prchal JT
Blood; 2014 Jan; 123(3):391-4. PubMed ID: 24297870
[TBL] [Abstract][Full Text] [Related]
14. In vitro culture growth of erythroid progenitors and serum erythropoietin assay in the differential diagnosis of polycythaemia.
Shih LY; Lee CT; See LC; Ou YC; Dunn P; Wang PN; Kuo MC; Wu JH
Eur J Clin Invest; 1998 Jul; 28(7):569-76. PubMed ID: 9726038
[TBL] [Abstract][Full Text] [Related]
15. Increase of CD34 positive cells in polycythaemia vera.
Andréasson B; Swolin B; Kutti J
Eur J Haematol; 1997 Sep; 59(3):171-6. PubMed ID: 9310125
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyurea treatment reduces haematopoietic progenitor growth and CD34 positive cells in polycythaemia vera and essential thrombocythaemia.
Andréasson B; Swolin B; Kutti J
Eur J Haematol; 2000 Mar; 64(3):188-93. PubMed ID: 10997885
[TBL] [Abstract][Full Text] [Related]
17. Patients with idiopathic myelofibrosis show increased CD34+ cell concentrations in peripheral blood compared to patients with polycythaemia vera and essential thrombocythaemia.
Andréasson B; Swolin B; Kutti J
Eur J Haematol; 2002 Apr; 68(4):189-93. PubMed ID: 12071933
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of alpha-globin locus chromatin structure and gene expression during erythroid differentiation of human CD34(+) cells in culture.
Mahajan MC; Karmakar S; Newburger PE; Krause DS; Weissman SM
Exp Hematol; 2009 Oct; 37(10):1143-1156.e3. PubMed ID: 19607874
[TBL] [Abstract][Full Text] [Related]
19. Distinct gene expression pattern of malignant hematopoietic stem and progenitor cells in polycythemia vera.
Steidl U; Schroeder T; Steidl C; Kobbe G; Graef T; Bork S; Pechtel S; Kliszewski S; Kuendgen A; Rohr UP; Fenk R; Schroeder M; Haase D; Haas R; Kronenwett R
Ann N Y Acad Sci; 2005 Jun; 1044():94-108. PubMed ID: 15958702
[TBL] [Abstract][Full Text] [Related]
20. Anti-erythropoietin (EPO) receptor monoclonal antibodies distinguish EPO-dependent and EPO-independent erythroid progenitors in polycythemia vera.
Fisher MJ; Prchal JF; Prchal JT; D'Andrea AD
Blood; 1994 Sep; 84(6):1982-91. PubMed ID: 8081000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
